Searched for
GENERIC ANTI CANCER MEDICATION
If you are sitting for over 30 mins at work: A new study warns this everyday office habit increases cancer risk; advises light movement for one hour a dayCancer risk of sitting too long: A study of over 91,000 UK Biobank participants has found that each additional hour of prolonged, uninterru...- Cancer ♋ Weekly Horoscope (6th July - 12th July 2026): Why This Week Could Be a Major Turning Point for CancerCancer Weekly Horoscope (6th July 2026 to 12th July 2026): This Cancer weekly horoscope suggests a week of learning and emotional balance. ...
- IITian gold medallist had a job offer worth Rs 2.5 crore, yet he chose a grocery storeAn IIT Bombay alumnus, Vivek Sharma, defied a lucrative US job offer to care for his ailing parents in India. He rejected a $240,000 annual...
- Even regular exercise can't beat the damage done by this common daily habit that increases cancer risk, scientists warnA new study by researchers at the University of Glasgow suggests that spending long, uninterrupted hours sitting may increase the risk of d...
- OnCare launches cancer treatment centre in BengaluruBengaluru now has a new cancer treatment centre launched by OnCare, aiming to bring accessible, affordable, and patient-friendly oncology s...
- Weekly Horoscope for ♋ CANCER (July 4 - July 10, 2026): Will Your Intuition Lead You to Powerful Success This Week?Cancer Weekly Horoscope (4th July 2026 to 10th July 2026): Cancer, this week marks a beautiful period of emotional renewal and personal gro...
- Less invasive oral cancer treatment: New IISc Bengaluru study finds ultrasound selectively kills tumor cells while sparing healthy onesNew IISc Bengaluru study: Researchers at the Indian Institute of Science have found that low-frequency ultrasound can selectively kill oral...
- Zydus Lifesciences ties up with Apollo Hospitals to offer Shield multi-cancer detection testZydus Lifesciences has partnered with Apollo Hospitals to introduce the Shield multi-cancer detection test in India, made possible through ...
- These large- and mid-cap stocks can give more than 20% return in 1 year, according to analystsIn just a few days, the Q1 earnings season for FY27 will start. But before that will come the season of business updates. And that needs to...
- Govt brings stem cell, gene therapies under central licensing frameworkIndia's drug regulations have been updated to include advanced treatments like cell, stem cell, gene therapies, and xenografts under centra...
- Scientists believed 'junk DNA' served no purpose but a new study says some of it actually helps stop cancer cells from growingJunk DNA cancer study: Researchers from Arizona State University and an international team have found that so-called junk DNA molecules, kn...
- Born on July 1, died on July 1: Who was Dr Bidhan Chandra Roy, in whose memory India celebrates National Doctors' Day?India observes National Doctors' Day on July 1, honoring medical professionals and commemorating the remarkable life of Dr. Bidhan Chandra ...
- 'Cheaper than a gym, but still not selling': Nithin Kamath on why Indians aren't embracing popular weight-loss drugsDespite rising obesity and affordable generic GLP-1 drugs, India lags in adoption. Nithin Kamath highlights patient retention challenges wi...
- Should they now be part of a long-term investing framework? 7 healthcare stocks with upside potential of up to 25%India’s healthcare market may grow steadily, but hospital chains can grow faster as formalisation continues. Healthcare is all about market...
- Kiran Mazumdar-Shaw warns against long-term GLP-1 use, urges caution over weight-loss drugs, says 'for those who are not diabetic or clinically obese...'Nithin Kamath questions India's slow adoption of affordable GLP-1 weight-loss drugs, despite rising obesity. He points to challenges like l...
- India’s GLP-1 boom loses steam as price war, weak retention hit generic weight-loss drug salesInitial excitement for India's generic weight-loss drugs is fading. Domestic manufacturers are lowering sales targets due to slower-than-ex...
- Alembic Pharma gets USFDA nod for generic influenza treatment drugAlembic Pharmaceuticals has secured USFDA approval for its generic oseltamivir phosphate oral suspension, a key treatment for influenza. Th...
- Lupin gets USFDA tentative approval for prostate cancer treatment drugIndian pharmaceutical giant Lupin Ltd has secured tentative approval from the US FDA for its generic enzalutamide tablets, a crucial treatm...
- Indian pharma firms gear up to supply key cancer drug to USIndian drugmakers are stepping up to help the US combat a critical shortage of ifosfamide injection, a vital chemotherapy drug. Leading com...
- Alembic Pharma gets tentative nod from USFDA for generic cancer drugAlembic Pharmaceuticals has secured tentative approval from the USFDA for its generic Binimetinib tablets. This marks a significant step fo...
Load More
